Abstract / Description: 

As a graduate student, Ira Memaj began exploring the health disparities that impact many Black Americans. The Detroit grown researcher’s first project was geared to investigating chemo-resistance in ovarian cancer cells leading her to produce over 16 publications in gynecological oncology including ovarian cancer, adhesions, and fibroids. This then inspired to her work at Wayne State University School of Medicine where she was part of a team that patented an antibody, CD11b, as a possible therapeutic agent for ovarian cancer.

Collection: 
eCardio Hub Collection
Category: 
COVID-19 Impact on Minority Health
Date: 
2020
Author: 
Brittany Chambers